Andrew Davenport

University College London Center for Nephrology, Royal Free Hospital, United Kingdom

Andrew Davenport MD

Academic positions:
- Consultant/honorary senior lecturer.

All industry positions (in last five years):
- Attended an advisory meeting for Trigen.

Research interests:
- Clinical management of acute kidney injury, haemodialysis, peritoneal dialysis.

Any other information:
-Past Director - International society of haemodialysis (2000-2006).
-Editorial Board - Kidney International, Nephron clinical practice, Blood Purification.
-Committee Member - International Society of Blood Purifucation, Acute Dialysis Quality Initiative (ADQI), Acute Kidney International Network (AKIN).
-Standards Committee Member - UK Renal Association.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Acute Renal Failure (since 11 November 2005)

All recent recommendations

• 3.0
  Five-year outcomes of severe acute kidney injury requiring renal replacement therapy.
  Recommended by Andrew Davenport
  
• 3.0
  Dosing intermittent haemodialysis in the intensive care unit patient with acute renal failure--estimation of urea removal and evidence for the regional blood flow model.
  Recommended by Andrew Davenport
  
• 4.9
  Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury.
  Recommended by Andrew Davenport, Esteban Poch with Nuria Serra Cabanas, Ravindra Mehta with Etienne Macedo
  
• 10.5
  Intensity of renal support in critically ill patients with acute kidney injury.
  Recommended by Achim Joerres, Andrew Davenport, John Laffey, Greg Martin, Giuseppe Remuzzi with Arrigo Schieppati, Heleen Oudemans-van Straaten, William Mitch
  
• 4.9
  Duration of red-cell storage and complications after cardiac surgery.
  Recommended by Andrew Davenport, Alan Merry with Craig Webster, Martin Dunser
  Dissent by Neil Blumberg, Shailendra Joshi
• 3.0
  Standard versus High-Dose CVVHDF for ICU-Related Acute Renal Failure.
  Recommended by Andrew Davenport
  
• 3.3
  Tight blood glucose control is renoprotective in critically ill patients.
  Recommended by Catherine Bouman, Peter Stenvinkel, Andrew Davenport
  
• 4.9
  VEGF inhibition and renal thrombotic microangiopathy.
  Recommended by Andrew Davenport, Terence H Cook with Candice Roufosse, David Salant with Ramon G Bonegio
  
• 5.5
  Vasopressin versus norepinephrine infusion in patients with septic shock.
  Recommended by Francis Leclerc, Andrew Davenport, Didier Journois with Guillaume Dubreuil, Jiri Horak, Eric Nylen with Nitin Seam, Martin Dunser, John Myburgh, Patrick Ray, Jacob Sznajder with Gökhan M Mutlu
  
• 7.5
  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
  Recommended by Michael O'Connor, Andrew Davenport, Jean-Charles Preiser, Alain Vuylsteke, Mark Hamilton with Marcus Peck, Marius Terblanche with Luigi Camporota, Simon Nadel, John Myburgh, Martin Dunser
  
• 3.0
  Association of oral sodium phosphate purgative use with acute kidney injury.
  Recommended by Andrew Davenport
  
• 3.0
  Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.
  Recommended by Andrew Davenport
  
• 3.0
  Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography.
  Recommended by Andrew Davenport
  
• 3.0
  High volume peritoneal dialysis for acute renal failure.
  Recommended by Andrew Davenport
  
• 3.0
  Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure.
  Recommended by Andrew Davenport
  
• 3.0
  Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
  Recommended by Andrew Davenport
  
• 3.0
  NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.
  Recommended by Andrew Davenport
  
• 3.0
  Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
  Recommended by Andrew Davenport
  
• 3.0
  Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
  Recommended by Andrew Davenport
  
• 4.9
  Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial.
  Recommended by Andrew Davenport, Greg McAnulty, Patrick Neligan
  
• 4.9
  N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
  Recommended by Greg McAnulty, Andrew Davenport, Samuel Heyman
  
• 3.0
  Declining mortality in patients with acute renal failure, 1988 to 2002.
  Recommended by Andrew Davenport
  
• 3.0
  Early isovolaemic haemofiltration in oliguric patients with septic shock.
  Recommended by Andrew Davenport
  
• 6.9
  The risk associated with aprotinin in cardiac surgery.
  Recommended by Andrew Davenport, Manfred Seeberger, Anneke Brand, Philippe de Moerloose, Chris Prowse
  Dissent by Neil Blumberg
• 6.0
  Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
  Recommended by Andrew Davenport
  
• 3.0
  Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
  Recommended by Andrew Davenport